Rosanne Yang is an associate in the firm’s Business Law Department and a member of its nationally recognized Technology and Life Sciences groups. Ms. Yang is a business lawyer who represents public and private companies and investors throughout the full range of the corporate life cycle, including startup and formation matters, venture capital financings, mergers and acquisitions, initial public offerings and capital markets transactions, and other complex transactions. Ms. Yang also represents a number of publicly traded companies in ongoing SEC compliance, capital raising and corporate governance matters. She joined Goodwin in 2018.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Representative Matters

REFERENZMANDATE

代表事项

Public Offerings
  • Represented Calliditas Therapeutics AB in its initial public offering in the United States
  • Represented Esperion Therapeutics in its upsized $280 million convertible notes offering with capped call
  • Represented Xeris Pharmaceuticals in (1) its $85 million and $37 million follow-on public offerings, (2) its $95 million concurrent equity and convertible notes offerings (3) its $50 million “at-the-market facility,” and (4) its convertible notes exchange
  • Financings

    Investor-side

    • Represented Royalty Pharma in its purchases of royalties in multiple transactions
    • Represented Eventide Asset Management in its investment in the Series D Preferred Stock financing of Prometheus Biosciences
    • Represented Deerfield Management in its investment in the Series A Preferred Stock financing of an early-stage pharmaceutical company
    • Represented OMRES in its investment in the Series A Preferred Stock financing of Quorso Global, Inc.
    • Represented 5AM Ventures in its investment in the Series A Preferred Stock financing of Artiva Biotherapeutics, Inc.
    • Represented Romulus Capital in its numerous investments in portfolio companies

    Company-side

    • Represented EQRx, Inc. in its $500 million Series B Preferred Stock financing
    • Represented EQRx, Inc. in its $200 million Series A Preferred Stock financing
    • Represented Valo Health. in its $190 million Series B Preferred Stock financing
    • Represented SpringWorks Therapeutics in its $125 million Series B Preferred Stock financing
    • Represented a biotechnology company in its $94 million Series A Preferred Stock financing
    • Represented a health services account platform and services company in its Series A Preferred Stock financing
    • Represented Esperion Therapeutics in its $200 million revenue-based financing
    • Represented Karyopharm Therapeutics in its $150 million revenue-based financing
    M+A — Corporate
    • Represented a leading public relations consulting firm in its sale to a public policy conglomerate
    • Represented a health services account platform and services company in an asset purchase transaction
    • Represented a biotechnology company in its acquisition of a data-driven drug design company
    • Represented Sansoro Health in its merger with Datica Health
    Professional Experience

    While at law school, Ms. Yang served as an editor of the Columbia Journal of European Law and a teaching assistant of International Banking and Finance. Ms. Yang also worked as a judicial intern to the Honorable Marianne B. Bowler at the United States District Court for the District of Massachusetts and a corporate legal intern at TripAdvisor. Prior to law school, Ms. Yang worked as an international consultant for the United Nations. She is Fluent in Mandarin and has a working knowledge of French.

    Recognition

    Ms. Yang was named a James Kent Scholar and Public Interest Honoree at Columbia Law School.

    In The News

    MELDUNGEN

    ACTUALITÉS

    相关新闻

    Credentials

    WERDEGANG

    RÉFÉRENCES

    专业资格

    Education

    J.D., 2018
    Columbia Law School
    (James Kent Scholar)
    M.A., 2013
    Sciences Po Paris
    LL.B., 2012
    Peking University

    Admissions

    Bar

    Massachusetts
    New York

    Languages

    Sprachen

    LANGUES

    语言

    Mandarin
    French
    Profile Image
    Get In Touch
    Kontakt
    NOUS CONTACTER
    联系我们
    Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

    Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

    Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

    客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

    Search Other Lawyers
    ANWALTSSUCHE
    Recherche par Pratique
    搜寻其他律师